Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 23, 2023 09:00 ET | Source: Intapp Inc.

Asana Partners selects DealCloud for deal and relationship management

PALO ALTO, Calif., May 23, 2023 (GLOBE NEWSWIRE) -- Intapp (NASDAQ: INTA), a leading provider of cloud software for the global professional and financial services industry, today announced that...
May 23, 2023 08:00 ET | Source: Avalyn Pharma Inc.

Avalyn Pharma Made Corporate and Clinical Presentations at ATS 2023 Including Results of Long-Term Treatment of Pulmonary Fibrosis with AP01

SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc., a clinical-stage biopharmaceutical company developing inhaled therapies to treat life-threatening pulmonary diseases, today presented...
May 23, 2023 08:00 ET | Source: QUADIENT

Quadient et la plateforme omnicanale OneRail s’associent pour proposer des solutions de livraison plus rapides et fluides

Paris Quadient (Euronext Paris : QDT), un opérateur majeur de consignes colis connectées dans le monde, et leader dans les technologies de gestion des communications clients, a annoncé aujourd'hui...
May 23, 2023 06:30 ET | Source: Kineta, Inc.

Kineta to Present at Jefferies Healthcare Conference

SEATTLE, May 23, 2023 (GLOBE NEWSWIRE) -- Kineta, Inc. (Nasdaq: KA), a clinical-stage biotechnology company focused on the development of novel immunotherapies in oncology that address cancer immune...
May 23, 2023 06:00 ET | Source: Minoa

Minoa Announces Close of $2.7 Million Pre-Seed Funding Round to Help SaaS Vendors Dramatically Improve Sales through Better Customer Collaboration

SAN FRANCISCO, May 23, 2023 (GLOBE NEWSWIRE) -- Minoa, developers of software-driven value and pricing management solutions for more effective enterprise SaaS sales, today announced the close of an...
May 23, 2023 03:00 ET | Source: AnaMar AB

AnaMar Announces Positive Phase I Data for its Phase II Ready Compound AM1476 for Treating Fibrosis

First-in-class, peripheral serotonin (5-HT2B) receptor antagonist being developed as a highly selective, oral, anti-fibrotic medicine for skin and lung disorders LUND, Sweden, May 23, 2023 (GLOBE...
May 23, 2023 01:53 ET | Source: Junshi Biosciences

Junshi Biosciences Announces Acceptance of the Supplemental NDA for Toripalimab in Combination with Chemotherapy for Advanced Triple-negative Breast Cancer

SHANGHAI, China, May 23, 2023 (GLOBE NEWSWIRE) -- Shanghai Junshi Biosciences Co., Ltd (“Junshi Biosciences”, HKEX: 1877; SSE: 688180), a leading innovation-driven biopharmaceutical company...
May 22, 2023 16:05 ET | Source: Zoom Video Communications, Inc.

Zoom Video Communications Reports Financial Results for the First Quarter of Fiscal Year 2024

First quarter total revenue of $1,105.4 million, up 3% year over year as reported and 5% in constant currencyFirst quarter Enterprise revenue of $632.0 million, up 13% year over yearFirst quarter GAAP...
May 22, 2023 16:05 ET | Source: Terns Pharmaceuticals, Inc.

Terns Pharmaceuticals to Highlight New Preclinical Data for TERN-601 Program in Obesity at the American Diabetes Association’s 83rd Annual Scientific Sessions

FOSTER CITY, Calif., May 22, 2023 (GLOBE NEWSWIRE) -- Terns Pharmaceuticals, Inc. (“Terns” or the “Company”) (Nasdaq: TERN), a clinical-stage biopharmaceutical company developing a portfolio of...
May 22, 2023 16:00 ET | Source: HiberCell, Inc.

HiberCell Doses First Patient in Phase 1b Study Exploring Novel Combination of Odetiglucan and CD40 Agonistic Monoclonal Antibody (CDX-1140) in Patients With Metastatic Pancreatic Ductal Adenocarcinoma (PDAC) in the Maintenance Setting

BOSTON, May 22, 2023 (GLOBE NEWSWIRE) -- HiberCell, a clinical-stage biotechnology company developing therapeutics to address cancer relapse, metastasis, and resistance, today announced dosing of...